New Interventional Therapies beyond Stenting to Treat ST-Segment Elevation Acute Myocardial Infarction
Myocardial infarction remains the principal cause of death in Europe. In patients with ST-segment-elevation myocardial infarction (STEMI), a promptly revascularization with primary percutaneous intervention (PCI) has transformed prognosis in the last decades. However, despite increasing successful P...
Main Authors: | Pablo Vidal-Calés, Pedro L. Cepas-Guillén, Salvatore Brugaletta, Manel Sabaté |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Journal of Cardiovascular Development and Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2308-3425/8/9/100 |
Similar Items
-
Novel Biomarkers, ST‐Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention
by: Jay S. Shavadia, et al.
Published: (2020-07-01) -
Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention
by: Francesco Pelliccia, et al.
Published: (2023-12-01) -
Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST‐Segment–Elevation Myocardial Infarction
by: Suzanne de Waha, et al.
Published: (2024-09-01) -
Ischemic postconditioning reduces infarct size and microvascular obstruction zone in acute ST-elevation myocardial infarction – a randomized study
by: Aleksander Araszkiewicz, et al.
Published: (2019-09-01) -
Diazoxide is a powerful cardioprotectant but is not feasible in a realistic infarct scenario
by: Petra Kleinbongard, et al.
Published: (2023-04-01)